Long QT Syndrome D008133

Related MeSH Hierarchy (4)

Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Arrhythmias, Cardiac » Long QT Syndrome

Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Cardiac Conduction System Disease » Long QT Syndrome

Description

A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.   MeSH

Subtype Terms (3)

Andersen Syndrome
2 drugs (1 approved, 1 experimental)

Romano-Ward Syndrome
2 drugs (1 approved, 1 experimental)


Phase 1 Indicated Drugs (3)


Organization Involved with Phase 3 Indications (1)

Organization Involved with Phase 2 Indications (3)

Organization Involved with Other Experimental Indications (2)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.